<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><description>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 16 Mar 2021 17:20:32 +0800</pubDate><image><url>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>司美格鲁肽治疗NASH获CDE拟突破性疗法认定</title><link>https://mp.weixin.qq.com/s/izfAtsY6SLDaF_82IGsLaQ</link><description></description><content:encoded><![CDATA[司美格鲁肽治疗NASH获CDE拟突破性疗法认定]]></content:encoded><pubDate>Tue, 16 Mar 2021 17:16:43 +0800</pubDate></item><item><title>辉瑞JAK1抑制剂在华上市申请拟纳入优先审评，治疗特应性皮炎</title><link>https://mp.weixin.qq.com/s/SFvPTCvE19QUQtcEmgiFDw</link><description></description><content:encoded><![CDATA[辉瑞JAK1抑制剂在华上市申请拟纳入优先审评，治疗特应性皮炎]]></content:encoded><pubDate>Tue, 16 Mar 2021 17:16:43 +0800</pubDate></item><item><title>首个宫颈癌2线疗法 III 期研究成功！</title><link>https://mp.weixin.qq.com/s/boYZ1VE-yvLtcRE4d9l5Xw</link><description></description><content:encoded><![CDATA[首个宫颈癌2线疗法 III 期研究成功！]]></content:encoded><pubDate>Tue, 16 Mar 2021 17:16:43 +0800</pubDate></item><item><title>首家！重庆药友递交抗精神病药上市申请</title><link>https://mp.weixin.qq.com/s/y6UgkUWryw8GDi7tbQBXcw</link><description></description><content:encoded><![CDATA[首家！重庆药友递交抗精神病药上市申请]]></content:encoded><pubDate>Tue, 16 Mar 2021 17:16:43 +0800</pubDate></item><item><title>AD/PD 2021：Biogen公布阿尔茨海默症新药aducanumab III期研究数据</title><link>https://mp.weixin.qq.com/s/hvq2LJVLY_zNpmdcyOM0VA</link><description></description><content:encoded><![CDATA[AD/PD 2021：Biogen公布阿尔茨海默症新药aducanumab III期研究数据]]></content:encoded><pubDate>Mon, 15 Mar 2021 18:39:15 +0800</pubDate></item><item><title>首仿！东阳光「恩他卡朋片」即将获批上市</title><link>https://mp.weixin.qq.com/s/X8uQ11-eWCj91chU5WvBXw</link><description></description><content:encoded><![CDATA[首仿！东阳光「恩他卡朋片」即将获批上市]]></content:encoded><pubDate>Mon, 15 Mar 2021 18:39:15 +0800</pubDate></item><item><title>冠脉扩张球囊类医用耗材集采来了，京津冀“3+N”联盟形成</title><link>https://mp.weixin.qq.com/s/4Mf66CxLrqa8aLY721ufKw</link><description></description><content:encoded><![CDATA[冠脉扩张球囊类医用耗材集采来了，京津冀“3+N”联盟形成]]></content:encoded><pubDate>Mon, 15 Mar 2021 18:39:15 +0800</pubDate></item><item><title>恩华药业1类抗抑郁新药获批临床</title><link>https://mp.weixin.qq.com/s/8KaG2SZKNs10lPn4omi2Bg</link><description></description><content:encoded><![CDATA[恩华药业1类抗抑郁新药获批临床]]></content:encoded><pubDate>Mon, 15 Mar 2021 18:39:15 +0800</pubDate></item><item><title>上海凯茂生物「注射用人干扰素γ」上市申请拟纳入优先审评</title><link>https://mp.weixin.qq.com/s/rC1ixpRTpMVyDwouYgqfKg</link><description></description><content:encoded><![CDATA[上海凯茂生物「注射用人干扰素γ」上市申请拟纳入优先审评]]></content:encoded><pubDate>Mon, 15 Mar 2021 18:39:15 +0800</pubDate></item><item><title>首仿！海思科「阿伐那非片」即将获批上市</title><link>https://mp.weixin.qq.com/s/cWc_eZRqUEOxET_ZmZtv-Q</link><description></description><content:encoded><![CDATA[首仿！海思科「阿伐那非片」即将获批上市]]></content:encoded><pubDate>Sat, 13 Mar 2021 13:13:36 +0800</pubDate></item><item><title>首仿！奥赛康「艾曲泊帕乙醇胺片」即将获批上市</title><link>https://mp.weixin.qq.com/s/8GmeSeqia6mH20YR_QmXsw</link><description></description><content:encoded><![CDATA[首仿！奥赛康「艾曲泊帕乙醇胺片」即将获批上市]]></content:encoded><pubDate>Sat, 13 Mar 2021 13:13:36 +0800</pubDate></item><item><title>FDA清查PD-1/L1药物，另有6项加速批准适应症可能撤回！事关默沙东、BMS、罗氏</title><link>https://mp.weixin.qq.com/s/X5xzoGHhrr8LatPURbaEoA</link><description></description><content:encoded><![CDATA[FDA清查PD-1/L1药物，另有6项加速批准适应症可能撤回！事关默沙东、BMS、罗氏]]></content:encoded><pubDate>Fri, 12 Mar 2021 12:27:58 +0800</pubDate></item><item><title>诺诚健华拟科创板上市</title><link>https://mp.weixin.qq.com/s/_CqCYFHxpijaonORq7MXqA</link><description></description><content:encoded><![CDATA[诺诚健华拟科创板上市]]></content:encoded><pubDate>Fri, 12 Mar 2021 12:27:58 +0800</pubDate></item><item><title>首仿！石药集团「尼达尼布软胶囊」获批上市</title><link>https://mp.weixin.qq.com/s/Uue3Qeg-J1BKp3gTbjpw0A</link><description></description><content:encoded><![CDATA[首仿！石药集团「尼达尼布软胶囊」获批上市]]></content:encoded><pubDate>Thu, 11 Mar 2021 19:48:47 +0800</pubDate></item><item><title>AACR21：礼来公布多个项目进展，KRAS G12C抑制剂活性提高近30倍</title><link>https://mp.weixin.qq.com/s/0Ib35shrF0CJECKerPjj-A</link><description></description><content:encoded><![CDATA[AACR21：礼来公布多个项目进展，KRAS G12C抑制剂活性提高近30倍]]></content:encoded><pubDate>Thu, 11 Mar 2021 19:48:47 +0800</pubDate></item><item><title>挑战阿尔兹海默症！恒瑞Aβ单抗获批临床</title><link>https://mp.weixin.qq.com/s/1_YpAdKWGhMOByux55HAYg</link><description></description><content:encoded><![CDATA[挑战阿尔兹海默症！恒瑞Aβ单抗获批临床]]></content:encoded><pubDate>Thu, 11 Mar 2021 19:48:47 +0800</pubDate></item><item><title>改良型新药！齐鲁孟鲁司特钠新剂型获批上市</title><link>https://mp.weixin.qq.com/s/4ZW_upf8x-XG0v7aglX1mg</link><description></description><content:encoded><![CDATA[改良型新药！齐鲁孟鲁司特钠新剂型获批上市]]></content:encoded><pubDate>Thu, 11 Mar 2021 19:48:47 +0800</pubDate></item><item><title>死亡风险降低92%！普克鲁胺治疗COVID-19重症患者临床研究结果公布</title><link>https://mp.weixin.qq.com/s/KDjQ9iAcSb-nWtobk1RObg</link><description></description><content:encoded><![CDATA[死亡风险降低92%！普克鲁胺治疗COVID-19重症患者临床研究结果公布]]></content:encoded><pubDate>Thu, 11 Mar 2021 19:48:47 +0800</pubDate></item><item><title>迪哲医药科创板IPO，首次对外披露全部管线，拟募资17.83亿元</title><link>https://mp.weixin.qq.com/s/zIe7LojUdUBdCJ48cffqKA</link><description></description><content:encoded><![CDATA[迪哲医药科创板IPO，首次对外披露全部管线，拟募资17.83亿元]]></content:encoded><pubDate>Wed, 10 Mar 2021 18:05:50 +0800</pubDate></item><item><title>国内首个！拜耳PI3K抑制剂在华申报上市</title><link>https://mp.weixin.qq.com/s/ogT5OxMDGBo_4fAahGXk8Q</link><description></description><content:encoded><![CDATA[国内首个！拜耳PI3K抑制剂在华申报上市]]></content:encoded><pubDate>Wed, 10 Mar 2021 18:05:50 +0800</pubDate></item></channel></rss>